Tested solutions to solve new challenges: breaking silos key in future proofing clinical trial supply chains

With the Covid-19 pandemic underscoring the importance of robust supply chains in clinical trials, a way to future proof these channels may be so obvious that it is easy to overlook. Better cooperation amongst all partners, including trial sponsors and contract research organisations (CRO), is critical to prevent future disruptions in the supply chain, says Paula Pulsoni, senior director of clinical supply solutions at World Courier, a global specialty logistics provider. Disruptions should be seen as opportunities, Pulsoni tells Clinical Trials Arena. “But for us to see opportunities in the disruptions, we need to be ready,” she added. Pulsoni spoke today at Arena International’s Clinical Trial Supply Europe conference in Madrid.

For the full article, please visit Clinical Trials Arena.